Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 3, 1997, Pages 232-236

  Melvin, A J ^a,c   Burchett, S K ^d   Watts, D H ^a   Hitti, J ^a   Hughes, J P ^a,b   McLellan, C L ^a   King, P D ^a   Johnson, E J ^a   Williams, B L ^a   Frenkel, L M ^a   Coombs, R W ^a  

^a Pathol and Lab Medicine Service   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

HIV 1; Pregnancy; Viral load

Indexed keywords

VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PREGNANCY COMPLICATION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIRUS CULTIVATION; WASHINGTON; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0030970791     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199703010-00006     Document Type: Article

References (20)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994;271:1925-30.
3. Frenkel LM, Wagner LE, Demeter LM, et al. Effects of zidovudine use during pregnancy on resistance and mother-to-child transmission of human immunodeficiency virus type I. Clin Infect Dis 1995;20:1321-6.
4. Weiser B, Nachman S, Tropper P, Viscosi KH, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci USA 1994;91:8037-41.
5. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
6. Hollinger FB, Bremer JW, Meyers LE, Gold JWM, McQuay L, and the NIH/NIAID/DAIDS/ACTG Virology Laboratories. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical trials group. J Clin Microbiol 1992;30:1787-94.
7. Gupta P, Enrico A, Armstrong J, Doerr M, Ho M, Rinaldo C. A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. AIDS Res Hum Retroviruses 1990;6:1193-6.
8. Pachl C, Todd JA, Kern DG, Sheridan PJ, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched chain DNA signal amplification assay. J AIDS 1995;8:446-54.
9. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
10. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974:124.
11. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974:109.
12. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:RR-17,1-18.
13. Alger LS, Parley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993;82:787-96.
14. Berrebi A, Kobuch WE, Puel J, et al. Influence of pregnancy on human immunodeficiency virus disease. Eur J Obstet Gynecol Rep Biol 1990;37:211-7.
15. Minkoff HL, Willoughby A, Mendez H, et al. Serious infections during pregnancy among women with advanced immunodeficiency virus infection. Am J Obstet Gynecol 1990;162:30-4.
16. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-94.
17. Minkoff HL, Henderson C, Mendez H, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990;163:1598-604.
18. Piatek M, Saag MS, Yang LC, et al. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 1993;7:565-71.
19. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retro 1995;11:353-61.
20. Lu W, Andrieu J-M. Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reaction. J Infect Dis 1993;167:1014-20.